Jimbo - I spoke with the CEO of LaJolla Diagnostics (LAJD) today. Brief conversation as he was being photographed for some PR. Here are the bits that I got so far:
11 mill shares outstanding, 4 mill closely held (some restricted stock not exercisable til yr. 2001. This leaves approx. free trading of about 2.5 mill.
From their web site:
La Jolla Diagnostics Inc. is a publicly held corporation with corporate headquarters in La Jolla, California, and laboratory facilities nearby. The Company's management and scientists have extensive expertise in a wide variety of health care areas including basic science, clinical investigation, product development and marketing and dealing with the FDA.
Some of the Company's products are based on a unique patented technology, "ClusterWater"(U.S. Patent 5711950).
La Jolla Diagnostics has two divisions, a Health Care Products Division which is developing and marketing ophthalmic solutions, nasal sprays, and licensing technologies for drug delivery, and a Diagnostic Division which is developing and marketing diagnostic products. In addition the Company has a working relationship with some of the premier scientific leaders of Russia and other countries of the ex-Soviet Union.
Their recent news release: quote.yahoo.com
These products will be prepared using water processed by a recently patented technology* to form ClusterWater(TM). While remaining chemically identical with unprocessed water, ClusterWater forms polywater complexes which enhance the effectiveness of biological solutions. *U.S. Patent 5711950
ClusterWater is also used in the formulation of the following products for which La Jolla Diagnostics is beginning to receive bulk orders:
Feverfew Nasal Mist(TM), a patent pending moisturizing nasal spray,
MigraSpray(TM) a saline solution containing the herb feverfew (commonly used as a treatment for migraine headaches) and designed to be sprayed under the tongue,
Living Water Eye Lotion(TM), a saline solution which cleanses and soothes the eye without interfering with natural functions, and
OptoPet(TM) Eye Wash for cleansing the eyes of dogs and cats and removing mucous which causes fur stains beneath the eyes, a major problem in certain breeds.
The new products which they are currently working on patenting will incorporated their already patented product for use in nasal spray and allergy treatment but has a "new type of treatment delivery" about which Mr. Brucker could not be specific until patenting process is further along. They are selling their antisera inventory as they feel the more recent products are more popular.
Interesting accumulation going on.
Charger |
